HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Inhibition of tumor necrosis factor-alpha-converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats.

Abstract
Tumor necrosis factor alpha (TNFalpha) is an immunomodulatory and proinflammatory cytokine implicated in neuroinflammation and neuronal damage in response to cerebral ischemia. Tumor necrosis factor-alpha converting enzyme (TACE or ADAM17) is a key sheddase that releases TNFalpha from its inactive cell-bound precursor. Using a selective small molecule inhibitor of TACE, DPH-067517, we tested the hypothesis that inhibition of TNFalpha formation might have a salutary effect in ischemic stroke induced by embolic occlusion of the middle cerebral artery (MCAO). DPH-067517 selectively inhibited TACE enzyme activity in vitro (K(i) = 2.8 nM), and effectively suppressed ischemia-induced increase in soluble TNFalpha in brain tissue after systemic administration. DPH-067517 (3 and 30 mg/kg, i.p. administered 15 min before MCAO) produced 43% (n = 8, p = 0.16) and 58% (n = 8, p < 0.05) reduction in infarct size and 36% (p < 0.05) and 23% (p < 0.05) reduction in neurological deficits, respectively. The salutary effect of DPH-067517 in ischemic brain injury was also observed when the first dose was administrated 60 min after the onset of ischemia. Inhibition of TACE had no effect on apoptosis measured by levels of active caspase-3 expression and DNA fragmentation. Our data suggest that inhibition of TACE might be a potential therapeutic strategy for neuroprotection after focal ischemic stroke.
AuthorsXinkang Wang, Giora Z Feuerstein, Lin Xu, Hugh Wang, William A Schumacher, Martin L Ogletree, Rebecca Taub, James J-W Duan, Carl P Decicco, Rui-Qin Liu
JournalMolecular pharmacology (Mol Pharmacol) Vol. 65 Issue 4 Pg. 890-6 (Apr 2004) ISSN: 0026-895X [Print] United States
PMID15044618 (Publication Type: Journal Article)
Chemical References
  • DPH-067517
  • Neuroprotective Agents
  • Piperidines
  • Quinolines
  • Casp3 protein, rat
  • Caspase 3
  • Caspases
  • ADAM Proteins
  • Metalloendopeptidases
  • tumor necrosis factor-alpha convertase
Topics
  • ADAM Proteins
  • Animals
  • Apoptosis
  • Brain Ischemia (prevention & control)
  • Caspase 3
  • Caspases (metabolism)
  • DNA Fragmentation (drug effects)
  • Gene Expression (drug effects)
  • Ischemia (complications)
  • Male
  • Metalloendopeptidases (antagonists & inhibitors, metabolism)
  • Neuroprotective Agents (pharmacology, therapeutic use)
  • Piperidines (pharmacology, therapeutic use)
  • Quinolines (pharmacology, therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: